Abstract

Next-generation sequencing (NGS) has revolutionized drug discovery by enabling comprehensive genomic analysis at unprecedented speed and depth. This technology has transformed pharmaceutical research by facilitating the identification of disease mechanisms, biomarkers, and potential drug targets with high precision. By providing insights into genetic variations, gene expression profiles, and molecular pathways associated with diseases, NGS has accelerated the development of personalized medicine approaches. This abstract explores the profound impact of NGS on pharmaceutical research, emphasizing its role in advancing precision medicine and enhancing the efficiency of drug development processes.